Pancreatic Cancer Incidence and Mortality by Year, Black Individuals, New York State, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 203 15.3 13.0-17.7 85 14.5 11.3-18.3 118 15.4 12.6-18.7 189 13.4 11.4-15.7 89 15.0 11.7-18.9 100 12.3 9.8-15.1
1977 200 14.1 12.0-16.4 105 17.8 14.0-22.2 95 11.6 9.2-14.3 182 12.8 10.8-15.0 99 16.9 13.3-21.2 83 10.1 7.9-12.7
1978 218 15.3 13.2-17.7 101 16.3 12.9-20.4 117 14.3 11.7-17.4 184 12.5 10.6-14.7 82 13.5 10.4-17.2 102 11.8 9.5-14.5
1979 229 16.1 13.9-18.6 113 19.1 15.3-23.5 116 14.1 11.5-17.0 203 14.3 12.2-16.6 87 13.4 10.5-16.9 116 14.3 11.7-17.4
1980 208 13.7 11.8-15.9 112 18.7 15.0-23.1 96 10.6 8.5-13.0 177 11.9 10.1-13.9 96 16.6 13.0-20.8 81 9.1 7.1-11.4
1981 239 15.5 13.4-17.7 127 20.8 17.0-25.2 112 12.1 9.8-14.7 201 12.9 11.1-15.0 108 17.4 13.8-21.5 93 10.2 8.1-12.5
1982 236 14.9 13.0-17.1 103 17.1 13.6-21.2 133 13.7 11.4-16.3 226 14.6 12.6-16.7 100 17.4 13.8-21.6 126 13.1 10.8-15.7
1983 269 15.7 13.8-17.9 130 19.0 15.5-22.9 139 13.6 11.4-16.2 243 14.5 12.7-16.6 126 19.6 15.9-23.7 117 11.5 9.4-13.9
1984 261 15.6 13.7-17.7 114 18.1 14.5-22.1 147 14.3 12.0-16.9 233 13.9 12.1-15.9 117 18.6 15.0-22.7 116 11.2 9.2-13.5
1985 242 13.9 12.1-15.8 125 17.7 14.5-21.5 117 11.3 9.3-13.6 206 12.2 10.5-14.1 103 15.9 12.7-19.7 103 10.1 8.1-12.2
1986 259 14.3 12.5-16.2 115 15.5 12.6-18.9 144 13.2 11.1-15.6 224 12.7 11.0-14.6 104 14.3 11.4-17.6 120 11.5 9.5-13.7
1987 281 15.1 13.3-17.1 125 16.6 13.5-20.1 156 13.9 11.8-16.3 242 13.1 11.4-14.9 106 15.3 12.1-18.9 136 11.9 9.9-14.1
1988 274 14.9 13.2-16.9 131 18.8 15.5-22.7 143 12.6 10.6-14.9 216 11.8 10.2-13.6 110 15.0 12.1-18.4 106 9.6 7.8-11.7
1989 255 13.4 11.7-15.2 104 14.4 11.5-17.7 151 12.7 10.7-15.0 234 12.4 10.8-14.1 99 13.6 10.8-16.8 135 11.5 9.6-13.6
1990 297 15.9 14.0-17.9 121 17.7 14.3-21.4 176 15.0 12.8-17.4 243 12.8 11.2-14.6 90 13.0 10.1-16.3 153 12.8 10.8-15.0
1991 256 13.0 11.4-14.8 124 16.4 13.4-19.9 132 11.0 9.2-13.1 221 11.1 9.6-12.7 111 14.2 11.4-17.4 110 9.1 7.5-11.0
1992 261 13.1 11.5-14.8 104 14.2 11.3-17.5 157 12.5 10.6-14.7 205 10.8 9.3-12.4 81 12.3 9.5-15.6 124 10.2 8.5-12.2
1993 244 12.0 10.5-13.6 106 13.7 10.9-16.8 138 10.9 9.1-12.9 204 10.1 8.7-11.6 84 11.8 9.1-14.9 120 9.3 7.7-11.2
1994 296 14.2 12.6-16.0 124 15.6 12.8-18.9 172 13.3 11.4-15.5 257 12.6 11.0-14.2 104 13.6 10.9-16.6 153 11.9 10.1-14.0
1995 264 12.5 11.0-14.1 118 14.3 11.7-17.4 146 11.1 9.3-13.1 240 11.2 9.8-12.8 108 13.7 11.0-16.8 132 9.9 8.2-11.7
1996 305 13.7 12.2-15.4 122 14.3 11.7-17.2 183 13.3 11.4-15.4 242 11.1 9.7-12.6 95 11.7 9.3-14.5 147 10.7 9.1-12.6
1997 303 13.5 12.0-15.2 128 14.1 11.7-17.0 175 12.7 10.9-14.8 240 11.0 9.6-12.5 103 11.8 9.5-14.4 137 10.1 8.5-12.0
1998 292 12.8 11.3-14.3 111 12.3 10.0-15.1 181 12.8 11.0-14.8 257 11.5 10.1-13.0 102 11.6 9.3-14.3 155 11.2 9.5-13.1
1999 337 14.3 12.8-16.0 136 15.1 12.5-18.0 201 13.8 11.9-15.8 286 12.2 10.8-13.7 108 11.7 9.5-14.3 178 12.2 10.5-14.1
2000 320 13.5 12.0-15.0 110 12.0 9.7-14.5 210 14.0 12.2-16.1 256 10.7 9.4-12.1 109 12.2 9.9-14.8 147 9.8 8.2-11.5
2001 361 14.4 12.9-16.0 141 14.4 12.0-17.1 220 14.3 12.4-16.3 284 11.7 10.3-13.1 105 11.1 9.0-13.6 179 11.7 10.1-13.6
2002 345 13.6 12.2-15.1 144 14.0 11.7-16.7 201 12.9 11.2-14.9 288 11.4 10.1-12.8 134 13.1 10.9-15.7 154 9.9 8.4-11.6
2003 322 12.4 11.1-13.9 160 16.2 13.7-19.1 162 10.1 8.6-11.8 258 10.2 9.0-11.5 114 11.9 9.6-14.4 144 9.1 7.7-10.8
2004 341 12.8 11.5-14.3 144 13.6 11.3-16.2 197 12.1 10.4-13.9 294 11.1 9.8-12.5 133 13.3 11.0-15.9 161 9.8 8.3-11.4
2005 347 12.6 11.3-14.0 148 13.9 11.7-16.5 199 11.7 10.1-13.5 269 10.0 8.8-11.2 120 11.2 9.1-13.5 149 9.0 7.6-10.6
2006 405 14.4 13.0-15.9 171 15.0 12.7-17.6 234 13.7 12.0-15.6 277 9.9 8.8-11.2 115 10.7 8.7-12.9 162 9.4 8.0-11.0
2007 389 13.8 12.5-15.3 173 15.5 13.2-18.2 216 12.6 11.0-14.4 300 10.8 9.6-12.1 136 12.5 10.3-14.9 164 9.7 8.2-11.3
2008 380 13.2 11.9-14.6 150 12.8 10.8-15.2 230 13.0 11.4-14.9 308 10.8 9.6-12.1 123 11.2 9.2-13.5 185 10.6 9.1-12.2
2009 391 13.2 11.9-14.6 189 16.1 13.7-18.7 202 11.2 9.7-12.9 321 11.0 9.8-12.3 141 12.4 10.3-14.7 180 10.0 8.6-11.6
2010 421 13.8 12.5-15.2 192 15.7 13.4-18.2 229 12.5 10.9-14.2 297 10.1 9.0-11.3 131 11.0 9.1-13.1 166 9.4 8.0-10.9
2011 502 15.9 14.5-17.4 220 16.9 14.6-19.5 282 15.0 13.2-16.8 361 11.8 10.6-13.1 160 13.5 11.4-15.8 201 10.7 9.3-12.3
2012 481 14.6 13.3-16.0 196 14.9 12.8-17.3 285 14.5 12.8-16.3 372 11.3 10.2-12.6 141 10.4 8.7-12.4 231 11.9 10.4-13.6
2013 506 15.1 13.8-16.5 230 16.9 14.7-19.4 276 13.7 12.2-15.5 343 10.4 9.3-11.6 161 12.6 10.6-14.8 182 9.0 7.7-10.5
2014 502 14.4 13.2-15.8 225 15.4 13.4-17.7 277 13.5 12.0-15.2 349 10.3 9.2-11.4 151 10.8 9.1-12.8 198 9.8 8.4-11.2
2015 555 15.7 14.4-17.1 251 17.2 15.0-19.5 304 14.6 12.9-16.3 381 11.1 10.0-12.3 173 12.2 10.4-14.3 208 10.1 8.8-11.6
2016 541 14.9 13.7-16.2 251 16.8 14.7-19.1 290 13.4 11.9-15.1 401 11.1 10.0-12.3 197 13.4 11.5-15.5 204 9.4 8.2-10.9
2017 553 15.0 13.8-16.4 240 15.9 13.9-18.1 313 14.3 12.8-16.1 391 10.7 9.6-11.8 177 12.1 10.3-14.1 214 9.7 8.4-11.1
2018 576 15.2 13.9-16.5 255 16.4 14.4-18.6 321 14.2 12.6-15.8 392 10.4 9.4-11.5 163 10.7 9.1-12.6 229 10.0 8.7-11.4
2019 587 15.2 13.9-16.5 258 16.4 14.4-18.6 329 14.2 12.7-15.9 431 11.1 10.1-12.2 188 11.7 10.0-13.5 243 10.4 9.1-11.8
2020 532 13.2 12.1-14.4 247 14.9 13.0-16.9 285 12.0 10.6-13.5 393 9.9 8.9-11.0 189 11.8 10.1-13.7 204 8.7 7.5-10.0

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.